CN116059295A - Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof - Google Patents
Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof Download PDFInfo
- Publication number
- CN116059295A CN116059295A CN202111310608.0A CN202111310608A CN116059295A CN 116059295 A CN116059295 A CN 116059295A CN 202111310608 A CN202111310608 A CN 202111310608A CN 116059295 A CN116059295 A CN 116059295A
- Authority
- CN
- China
- Prior art keywords
- parts
- formula
- beautifying
- whitening
- white
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 230000002087 whitening effect Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 230000001815 facial effect Effects 0.000 claims abstract description 12
- 241001313857 Bletilla striata Species 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 11
- 238000006477 desulfuration reaction Methods 0.000 claims description 10
- 230000023556 desulfurization Effects 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 10
- 229910001385 heavy metal Inorganic materials 0.000 claims description 10
- 239000000447 pesticide residue Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 241001116389 Aloe Species 0.000 claims description 8
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000132012 Atractylodes Species 0.000 claims description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims description 8
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 8
- 241000222336 Ganoderma Species 0.000 claims description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 8
- 241001106477 Paeoniaceae Species 0.000 claims description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 235000008434 ginseng Nutrition 0.000 claims description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 8
- 235000011477 liquorice Nutrition 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- 244000036905 Benincasa cerifera Species 0.000 claims description 4
- 235000011274 Benincasa cerifera Nutrition 0.000 claims description 4
- 208000003351 Melanosis Diseases 0.000 abstract description 16
- 206010008570 Chloasma Diseases 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000001105 regulatory effect Effects 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 239000000047 product Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a formula for oral administration and external use of Yi medicine for whitening and beautifying, which is prepared from semen Benincasae, bletilla striata and the like, and has the effects of making the face glossy, beautifying and removing black scar. The above materials are ground into fine powder and taken with wine to assist the efficacy of the drugs by dispelling the effects of the wine. The formula can remove chloasma and whiten the face by the principle of regulating qi and activating blood. The oral and external Yi medicine is taken as a precondition of dietetic invigoration, can help human body to invigorate qi and blood, has the functions of conditioning viscera and balancing bodies, and is mainly used for beautifying and nourishing by regulating the channels and collaterals, qi and blood in the bodies. Therefore, the facial mask not only can effectively improve the effect of facial care, but also can play a role in regulating, supplementing and nourishing the body. The whitening and beautifying prescription disclosed by the invention has the advantages that a plurality of components are common Yi-nationality medicines, and the preparation is simple and the effect is good.
Description
Technical Field
The invention relates to a formula for oral administration and external use of Yi medicine for whitening and beautifying and a preparation method thereof.
Background
Skin whitening and beautifying are certainly the most important among the most interesting skin problems, but as the environment is worse and worse, the damage to the skin is also increased. So we often choose some whitening and beautifying products to care the skin in the market. Many of the products we choose are actually good, resulting in skin care products that perform well, but some do not perform well after use. Some of these products can even cause harm to our skin. The skin care products have the advantages that the skin can achieve better effect in a short time after being used due to the fact that a lot of lead and mercury components exist in the skin care products, but chemical components in the products can cause harm to the facial skin, and the skin starts to be rough and aged after being used. After we stop using such products our skin condition can become worse than before, and some can even be devastating. The external whitening product is capable of treating the symptoms and the root causes, and the real whitening is conditioned from inside to outside.
Disclosure of Invention
Therefore, the main purpose of the invention is to provide a formula for oral administration and external use of whitening and beautifying Yi-nationality medicine and a preparation method thereof, which have remarkable anti-inflammatory and analgesic effects and have no side effects.
In order to achieve the above purpose, the technical scheme of the invention is realized as follows: the formula for oral and external application of the whitening and beautifying Yi medicine is characterized by comprising the following components in parts by weight:
30 to 50 parts of rhizoma paridis, 20 to 30 parts of aloe, 30 to 60 parts of bletilla striata, 30 to 50 parts of rhizoma polygonati,
20 to 30 parts of lucid ganoderma, 20 to 50 parts of semen Benincasae, 19 to 40 parts of peach blossom, 5 to 30 parts of safflower,
10 to 30 parts of sun-dried ginseng, 30 to 50 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 5 to 30 parts of liquorice.
The invention also provides a preparation method of the formula for oral administration and external use of the whitening and beautifying Yi-nationality medicine, which is characterized by comprising the following steps of:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
it is administered orally in 35% (v/v) Chinese liquor.
As another object of the present invention, there is also provided a method for preparing a formulation for oral administration and external use of a whitening and skin-caring Yi medicine, comprising:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
the external use is added with 1 to 3 percent of salicylic acid and honey to prepare the facial mask or the extraction essence.
Compared with the prior art, the invention has the following beneficial effects:
the realization is simple, the white gourd seeds, the bletilla striata and the like make the noodles glossy, beautify the face and remove black spots. The above materials are ground into fine powder and taken with wine to assist the efficacy of the drugs by dispelling the effects of the wine. The formula can remove chloasma and whiten the face by the principle of regulating qi and activating blood. The oral and external Yi medicine is taken as a precondition of dietetic invigoration, can help human body to supplement qi and blood, has the functions of regulating viscera and balancing bodies, and is mainly used for maintaining beauty and keeping young by regulating the channels and collaterals, qi and blood in the bodies. Therefore, the facial mask not only can effectively improve the effect of facial care, but also can play a role in regulating, supplementing and nourishing the body. The whitening and beautifying prescription disclosed by the invention has the advantages that a plurality of components are common Yi-nationality medicines, and the preparation is simple and the effect is good.
Detailed Description
The following detailed description of specific embodiments of the invention is provided to facilitate a further understanding of the invention.
Example 1
A formula for oral administration and external use of whitening and beautifying Yi medicine comprises the following components in parts by weight:
30 parts of rhizoma paridis, 20 parts of aloe, 30 parts of bletilla striata, 30 parts of rhizoma polygonati,
20 parts of lucid ganoderma, 20 parts of white gourd seed, 19 parts of peach blossom, 5 parts of safflower,
10 parts of sun-dried ginseng, 30 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 5 parts of liquorice.
The preparation method of the formula for oral administration and external use of the whitening and beautifying Yi medicine of the embodiment comprises the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
it is administered orally in 35% (v/v) Chinese liquor.
The embodiment also provides a preparation method of the formula for oral administration and external use of the Yi medicine for whitening and nourishing skin, which comprises the following steps: weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
the external use is added with 1 to 3 percent of salicylic acid and honey to prepare the facial mask or the extraction essence.
Example 2
A formula for oral administration and external use of whitening and beautifying Yi medicine comprises the following components in parts by weight:
50 parts of rhizoma paridis, 30 parts of aloe, 60 parts of bletilla striata, 50 parts of rhizoma polygonati,
30 parts of lucid ganoderma, 50 parts of semen Benincasae, 40 parts of peach blossom, 30 parts of safflower,
30 parts of sun-dried ginseng, 50 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 30 parts of liquorice.
The preparation method of the formula for oral administration and external use of the whitening and beautifying Yi medicine of the embodiment comprises the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
it is administered orally in 35% (v/v) Chinese liquor.
The embodiment also provides a preparation method of the formula for oral administration and external use of the Yi medicine for whitening and nourishing skin, which comprises the following steps: weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
the external use is added with 1 to 3 percent of salicylic acid and honey to prepare the facial mask or the extraction essence.
Example 3
A formula for oral administration and external use of whitening and beautifying Yi medicine comprises the following components in parts by weight:
40 parts of rhizoma paridis, 25 parts of aloe, 45 parts of bletilla striata, 40 parts of rhizoma polygonati,
25 parts of lucid ganoderma, 35 parts of semen Benincasae, 29 parts of peach blossom, 18 parts of safflower,
20 parts of sun-dried ginseng, 40 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 18 parts of liquorice.
The preparation method of the formula for oral administration and external use of the whitening and beautifying Yi medicine of the embodiment comprises the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
it is administered orally in 35% (v/v) Chinese liquor.
The embodiment also provides a preparation method of the formula for oral administration and external use of the Yi medicine for whitening and nourishing skin, which comprises the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
the external use is added with 1 to 3 percent of salicylic acid and honey to prepare the facial mask or the extraction essence.
Clinical trial:
the internal use is as follows: the test method comprises the following steps: 70 chloasma subjects are divided into a test feeding group and a blank control group immediately, and two control forms of the subjects and the subjects are adopted.
Dosage and time: the trial eating group takes whitening and beautifying Yi nationality medicine 3 times a day, and the subject stops taking the medicine or other health care products and cosmetics for removing chloasma during the experimental period.
And (3) observing the indexes: the test is carried out once before and after the experiment, and the indexes comprise a safety index and an efficacy index. Wherein the safety index comprises blood, urine routine, stool routine examination, serum albumin ALB, total protein TP, heart, liver and kidney function, blood sugar GLU, blood lipid, abdomen B ultrasonic, electrocardiogram, X-ray chest perspective. Efficacy indicators include general condition and symptom observations.
Symptom observations include detailed inquiry history, knowledge of the subject's diet, observations of major clinical symptoms: tiredness, dysphoria, sleep, etc. The improvement rate was calculated according to the statistical integral values of the symptoms of the disease (major 3, middle 2, and minor 1) before and after the test diet, and the improvement of the main symptoms thereof (each symptom is improved by 2 and the improvement is effective by 1).
The detection of the chloasma on the head and the face of the subject is counted through the change of the size of the area and the color depth. Area size change by measuring the long and wide diameters of the same chloasma before and after the test with a ruler, the area (cm) was calculated 2 ) The method comprises the steps of carrying out a first treatment on the surface of the The color shade of chloasma is developed according to the design of the geographic institute of China academy of sciences, and the brown color card in the practical standard color card published in 1992 of mapping publishing society is a judgment standard of the color shade of chloasma. The efficacy of removing freckle is judged to be effective or ineffective. The effective means that the color of chloasma is reduced by I degrees or the area is reduced by more than 10 percent, and no new chloasma is generated. The control before and after the test feeding group and the control between the groups have significant differences. The ineffectiveness means that the area of chloasma is reduced by less than 10 percent, and the color is not obviously changed.
Test effect
70 cases of chloasma subjects are randomly divided into a test feeding group and a control group, and the area of the chloasma in the test feeding group is reduced by 3.75+/-6.01 cm on average 2 The color is lightened, the average color card is reduced by 0.33+/-0.35 ℃, 67 cases are effective, the total effective rate is 94%, and the average area of the chloasma in a control group is reduced by 0.38+/-1.35 cm 2 The color becomes lighter, and the average color chip is reduced by 0.05+/-0.21 degrees.
External test
The staff smears the face of the tested person, the smear area should be not less than 5cm 2 The coating amount is 1.00+/-0.07 mg/cm 2 . Performing evaluation and test of skin basic values before product use on qualified subjects in a group, including visual evaluation, instrument test and standard image shooting, and recording; the same evaluation and testing was again performed 2 weeks, 4 weeks, 8 weeks after product use.
Test effect: the total effective rate is 95%, the color is light, and the average color card is reduced by 0.07+/-0.23 degrees.
The invention has the remarkable effects that:
the realization is simple, the white gourd seeds, the bletilla striata and the like make the noodles glossy, beautify the face and remove black spots. The above materials are ground into fine powder and taken with wine to assist the efficacy of the drugs by dispelling the effects of the wine. The formula can remove chloasma and whiten the face by the principle of regulating qi and activating blood. The oral and external Yi medicine is taken as a precondition of dietetic invigoration, can help human body to supplement qi and blood, has the functions of regulating viscera and balancing bodies, and is mainly used for maintaining beauty and keeping young by regulating the channels and collaterals, qi and blood in the bodies. Therefore, the facial mask not only can effectively improve the effect of facial care, but also can play a role in regulating, supplementing and nourishing the body. The whitening and beautifying prescription disclosed by the invention has the advantages that a plurality of components are common Yi-nationality medicines, and the preparation is simple and the effect is good.
The foregoing description is only of the preferred embodiments of the present invention, and is not intended to limit the scope of the present invention.
Claims (6)
1. The formula for oral and external application of the whitening and beautifying Yi medicine is characterized by comprising the following components in parts by weight:
30 to 50 parts of rhizoma paridis, 20 to 30 parts of aloe, 30 to 60 parts of bletilla striata, 30 to 50 parts of rhizoma polygonati,
20 to 30 parts of lucid ganoderma, 20 to 50 parts of semen Benincasae, 19 to 40 parts of peach blossom, 5 to 30 parts of safflower,
10 to 30 parts of sun-dried ginseng, 30 to 50 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 5 to 30 parts of liquorice.
2. The formula for oral and external use of whitening and beautifying Yi medicine according to claim 1, which is characterized by comprising the following components in parts by weight:
30 parts of rhizoma paridis, 20 parts of aloe, 30 parts of bletilla striata, 30 parts of rhizoma polygonati,
20 parts of lucid ganoderma, 20 parts of white gourd seed, 19 parts of peach blossom, 5 parts of safflower,
10 parts of sun-dried ginseng, 30 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 5 parts of liquorice.
3. The formula for oral and external use of whitening and beautifying Yi medicine according to claim 1, which is characterized by comprising the following components in parts by weight:
50 parts of rhizoma paridis, 30 parts of aloe, 60 parts of bletilla striata, 50 parts of rhizoma polygonati,
30 parts of lucid ganoderma, 50 parts of semen Benincasae, 40 parts of peach blossom, 30 parts of safflower,
30 parts of sun-dried ginseng, 50 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 30 parts of liquorice.
4. The formula for oral and external use of whitening and beautifying Yi medicine according to claim 1, which is characterized by comprising the following components in parts by weight:
40 parts of rhizoma paridis, 25 parts of aloe, 45 parts of bletilla striata, 40 parts of rhizoma polygonati,
25 parts of lucid ganoderma, 35 parts of semen Benincasae, 29 parts of peach blossom, 18 parts of safflower,
20 parts of sun-dried ginseng, 40 parts of white paeony root, white atractylodes rhizome and white poria respectively, and 18 parts of liquorice.
5. A preparation method of a formula for oral administration and external use of whitening and beautifying Yi medicine is characterized by comprising the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
it is administered orally in 35% (v/v) Chinese liquor.
6. A preparation method of a formula for oral administration and external use of whitening and beautifying Yi medicine is characterized by comprising the following steps:
weighing the raw materials according to the formula, and carrying out treatments of pesticide residue removal, desulfurization and heavy metal removal;
grinding the above materials into fine powder;
the external use is added with 1 to 3 percent of salicylic acid and honey to prepare the facial mask or the extraction essence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111310608.0A CN116059295A (en) | 2021-11-03 | 2021-11-03 | Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111310608.0A CN116059295A (en) | 2021-11-03 | 2021-11-03 | Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116059295A true CN116059295A (en) | 2023-05-05 |
Family
ID=86172113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111310608.0A Pending CN116059295A (en) | 2021-11-03 | 2021-11-03 | Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116059295A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102000174A (en) * | 2010-12-05 | 2011-04-06 | 张宁 | Traditional Chinese medicine oral administration formula for whitening |
CN102648955A (en) * | 2012-05-03 | 2012-08-29 | 李春仪 | Skin whitening and freckle removing beautifying prescription |
CN107320636A (en) * | 2017-07-13 | 2017-11-07 | 谢红 | A kind of herbal composite with white-skinned face function |
CN107412359A (en) * | 2017-06-30 | 2017-12-01 | 禹州市合同泰药业有限公司 | A kind of prepared slices of Chinese crude drugs formula of beauty treatment and eliminating spot and preparation method thereof |
-
2021
- 2021-11-03 CN CN202111310608.0A patent/CN116059295A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102000174A (en) * | 2010-12-05 | 2011-04-06 | 张宁 | Traditional Chinese medicine oral administration formula for whitening |
CN102648955A (en) * | 2012-05-03 | 2012-08-29 | 李春仪 | Skin whitening and freckle removing beautifying prescription |
CN107412359A (en) * | 2017-06-30 | 2017-12-01 | 禹州市合同泰药业有限公司 | A kind of prepared slices of Chinese crude drugs formula of beauty treatment and eliminating spot and preparation method thereof |
CN107320636A (en) * | 2017-07-13 | 2017-11-07 | 谢红 | A kind of herbal composite with white-skinned face function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107126485B (en) | Traditional Chinese medicine composition for assisting in improving sleep and preparation method and application thereof | |
JP2018502079A (en) | Eurycoma longifolia extract and its use in enhancing and / or stimulating the immune system | |
US20120288454A1 (en) | Dental protection toothpaste composition | |
CN103356807A (en) | Drug composite with function of enhancing immunity and preparation method thereof | |
TW474815B (en) | A process for preparing the galenic composition for prophylaxis and treatment of after effects due to excessive alcohol intake | |
CN101032599B (en) | Healthy solution for conditioning skin and losing weight | |
CN108686023A (en) | A kind of antipruritic moisturizing essential oil for treating geroderma itch | |
CN116059295A (en) | Formula for oral administration and external use of whitening and beautifying Yi medicine and preparation method thereof | |
EP1819310A1 (en) | Compositions for the acute and/or long term treatment of periodontal diseases | |
CN102657811B (en) | Orally administered liquid for treating canker sore | |
CN106728387B (en) | Compound medicine with function of promoting immunity and preparation method thereof | |
CN113827652A (en) | Traditional Chinese medicine composition for treating migraine and preparation method and application thereof | |
Abascal et al. | Treatments for recurrent aphthous stomatitis | |
CN103830558A (en) | Anti-aging composition and preparation method thereof | |
CN112316051A (en) | Traditional Chinese medicine composition for nourishing blood and reducing phlegm as well as traditional Chinese medicine preparation, preparation method and application thereof | |
CN104394867B (en) | Containing purine derivative or the compositions for preventing or treat allergic dermatitis of its salt | |
CN112336764A (en) | Traditional Chinese medicine composition for resisting oxidation and enhancing immunity and preparation method and application thereof | |
CN106074696A (en) | A kind of health product being improved immunity of organisms and anti-fatigue effect by regulation and control content of nitric oxide technology | |
CN105816841A (en) | Traditional Chinese medicine acupoint patch for relieving fatigue | |
CN110664922A (en) | Composition with chloasma removing function and preparation method and application thereof | |
CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
CN105194352B (en) | A kind of Chinese medicine composition and preparation method thereof improving learning and memory | |
CN116211985B (en) | Traditional Chinese medicine composition for treating flat wart, traditional Chinese medicine preparation and application thereof | |
CN109758559A (en) | A kind of Chinese medicine composition and its preparation method and application for treating chronic fatigue syndrome | |
CN113876667B (en) | Compound five-vein green chorifola medicine composition with skin color brightening, anti-allergy and soothing effects and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230505 |
|
WD01 | Invention patent application deemed withdrawn after publication |